Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04676334
Title CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib (CATCH-R)
Acronym CATCH-R
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Age Groups: adult | senior
Covered Countries ITA | GBR | CAN

No variant requirements are available.